New Zealand markets close in 1 hour 20 minutes

Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
16.71+0.04 (+0.24%)
At close: 01:59PM CST

Genomma Lab Internacional, S.A.B. de C.V.

Av. Antonio Dovalí Jaime, number 70
tower C, floor 2 office "A". Colonia Santa Fe. Alvaro Obregón Mayor's Office
Mexico City, DF 01210
Mexico
52 55 5081 0000
https://www.genommalab.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Juan Marco SparvieriChief Executive OfficerN/AN/AN/A
Engineer Antonio Zamora GallandExecutive VP of Finance & Administration and CFON/AN/AN/A
Daniel Suarez NeriaHead of Investor RelationsN/AN/AN/A
Mr. Alejandro Bastón PatiñoExecutive Vice President of Institutional Relations, Media, Human Resources & SustainabilityN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.

Description

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.

Corporate governance

Genomma Lab Internacional, S.A.B. de C.V.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.